نتایج جستجو برای: cns relapse prophylaxis

تعداد نتایج: 167473  

Journal: :Medicina clinica 2008
Juan-Manuel Sancho Mireia Morgades Reyes Arranz Pascual Fernández-Abellán Guillermo Deben Natalia Alonso Margarita Blanes María José Rodríguez Concepción Nicolás Eva Sánchez Alberto Fernández de Sevilla Eulogio Conde Josep-Maria Ribera

BACKGROUND AND OBJECTIVE Central nervous system (CNS) involvement in patients diagnosed with acute leukemias (AL) is an uncommon complication with poor prognosis. The indication and the schedules of prophylaxis and treatment of CNS involvement in AL are not homogenous among countries and within the same country. The aim of this prospective longitudinal study was to analyze and report the practi...

Journal: :Lancet 2012
Tetsuya Tanimoto Eiji Kusumi Kazutaka Hosoda Fumihito Tajima Yasuo Oshima

Central nervous system (CNS) relapse is an uncommon devastating complication of diffuse large B-cell lymphoma (DLBCL) that usually occurs within 2 years from initial diagnosis. Its pathophysiology is poorly understood and there is no consensus on the definition of high-risk patients for CNS relapse. Consequently, an empirical and highly variable practice of chemoprophylaxis is employed. In this...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2012
R Alvarez J Dupuis A Plonquet C Christov C Copie-Bergman F Hemery I Gaillard T El Gnaoui F Kuhnowski M Bedoui K Belhadj P Brugières C Haioun

BACKGROUND Central nervous system (CNS) relapse is an uncommon but dramatic complication of diffuse large B-cell lymphoma (DLBCL). Several studies have demonstrated the superiority of cerebrospinal fluid (CSF) flow cytometry (FCM), as compared with conventional cytology (CC), in detecting occult leptomeningeal disease. The clinical relevance of a positive FCM still has to be clarified. PATIEN...

Journal: :Polskie Archiwum Medycyny Wewnetrznej 2008
Sebastian Giebel Małgorzata Krawczyk-Kuliś Maria Adamczyk-Cioch Anna Czyz Ewa Lech-Marańda Beata Piatkowska-Jakubas Monika Paluszewska Grazyna Pałynyczko Jarosław Piszcz Jerzy Hołowiecki

The central nervous system (CNS) is one of the most frequent extramedullary locations of adult acute lymphoblastic leukemia (ALL), affecting approximately 5% of patients at diagnosis. T-lineage ALL, high initial leukocyte counts and mediastinal involvement are the predisposing factors. In case of relapse, if no prophylaxis was administered, the rate of CNS involvement reaches 30-50%. As the pro...

Journal: :Pediatric hematology and oncology 1991
A Kreuger S Garwicz H Hertz G Jonmundsson M Lanning S O Lie P J Moe T T Salmi H Schröder M A Siimes

In the five Nordic countries, 808 children 1 to 15 years of age (428 boys, 380 girls) were diagnosed with non-B acute lymphoblastic leukemia (ALL) from July 1981 through June 1986. Complete remission was achieved in 770 children (95%). Central nervous system (CNS) involvement at diagnosis was noticed in 34 children, of whom 26 achieved remission. Of these 26 patients 11 subsequently relapsed, 5...

Journal: :Blood 1980
G A Omura S Moffitt W R Vogler M M Salter

Although major progress has been made in the treatment of childhood leukemia, the optimal chemotherapy of acute lymphoblastic leukemia (ALL) in adults has been unclear. In addition, the value of central nervous system prophylaxis (CNS-P) in adults has been assumed, but not established in a systematic fashion. The Southeastern Cancer Study Group has completed a prospective study in which the use...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2012
N Schmitz S Zeynalova B Glass U Kaiser E Cavallin-Stahl M Wolf M Haenel M Loeffler L Truemper M Pfreundschuh

BACKGROUND To describe incidence, risk factors, and influence of treatment on occurrence of central nervous system (CNS) relapse or progression in younger patients with aggressive B-cell lymphoma. PATIENTS AND METHODS We analyzed 2210 patients with aggressive B-cell lymphoma treated on various studies for CNS relapse/progression. Treatment consisted of CHOP (cyclophosphamide, doxorubicin, vin...

Journal: :International journal of cancer management 2021

Introduction: Primary breast lymphoma (PBL) is a rare form of extranodal lymphoma. The most common pathology diffuse large B cell and patients are diagnosed at stages 1 2. therapeutic options available so far include surgery, radiotherapy, chemotherapy Case Presentation: patient was 54-year old woman with localized primary B-cell (DLBCL). underwent 6 courses an R-CHOP regimen followed by radiot...

2017
Marta García-Recio Antonia Cladera Leyre Bento Julia Dominguez Silvia Ruiz de Gracia Francesca Sartori Raquel Del Campo Lucia García Carmen Ballester Jordi Gines Joan Bargay Antonia Sampol Antonio Gutiérrez

Central nervous system (CNS) lymphomatosis is a fatal complication of aggressive non-Hodgkin lymphoma (NHL). In lymphoblastic or Burkitt lymphoma, without specific CNS prophylaxis the risk of CNS relapse is 20-30%. DLBCL has a lower risk of relapse (around 5%) but several factors increase its incidence. There is no consensus or trials to conclude which is the best CNS prophylaxis. Best results ...

2018
Dai Chihara Michelle A Fanale Roberto N Miranda Mansoor Noorani Jason R Westin Loretta J Nastoupil Fredrick B Hagemeister Luis E Fayad Jorge E Romaguera Felipe Samaniego Francesco Turturro Hun J Lee Sattva S Neelapu M Alma Rodriguez Michael Wang Nathan H Fowler Richard E Davis L Jeffrey Medeiros Yasuhiro Oki

We performed a retrospective analysis to identify risk factors and survival outcome for central nervous system (CNS) relapse of peripheral T-cell lymphoma (PTCL) by histologic type. Records of 600 PTCL patients diagnosed between 1999 and 2014 were analyzed including PTCL not otherwise specified (PTCL-NOS, 174 patients), angoimmunoblastic T-cell lymphoma (AITL, 144), ALK+anaplastic large cell ly...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید